Definitive Healthcare Corp.

DH

US24477E1038

Software

Market Closed - Nasdaq Other stock markets 21:00:00 25/06/2024 BST			5-day change	1st Jan Change
5.15 ^USD	-3.92%		-7.54%	-48.19%

05-28	Definitive Healthcare Hires Kevin Coop as CEO	MT
05-24	Definitive Healthcare Corp. Announces Appointment of Kevin Coop as Member of the Board, Effective June 24, 2024	CI

Definitive Healthcare Corp. Reaffirms Earnings Guidance for the Fourth Quarter 2023 and Provides Earnings Guidance for the Full Year 2024

January 16, 2024 at 09:05 pm

Definitive Healthcare Corp. reaffirmed earnings guidance for the fourth quarter 2023.

For the full year 2024, the company expects revenue to grow 5%-7% compared to full year 2023 guidance.

Latest news about Definitive Healthcare Corp.

Definitive Healthcare Hires Kevin Coop as CEO	05-28	MT
Definitive Healthcare Corp. Announces Appointment of Kevin Coop as Member of the Board, Effective June 24, 2024	05-24	CI
Definitive Healthcare Corp. Announces Chief Executive Officer Changes, Effective June 24, 2024	05-24	CI
Transcript : Definitive Healthcare Corp. Presents at The 52nd J.P. Morgan Annual Global Technology, Media & Communications Conference, May-21-2024 10:10 AM	05-21
Barclays Adjusts Price Target on Definitive Healthcare to $7 From $11, Maintains Equal-Weight Rating	05-09	MT
Deutsche Bank Adjusts Definitive Healthcare Price Target to $7 From $10, Maintains Hold Rating	05-09	MT
Stifel Adjusts Price Target on Definitive Healthcare to $9.50 From $11, Maintains Buy Rating	05-08	MT
Morgan Stanley Downgrades Definitive Healthcare to Equalweight From Overweight, Cuts Price Target to $9 From $11.50	05-08	MT
Transcript : Definitive Healthcare Corp., Q1 2024 Earnings Call, May 07, 2024	05-07
Earnings Flash (DH) DEFINITIVE HEALTHCARE Reports Q1 Revenue $63.5M, vs. Street Est of $64M	05-07	MT
Earnings Flash (DH) DEFINITIVE HEALTHCARE Posts Q1 EPS $0.08, vs. Street Est of $0.08	05-07	MT
Definitive Healthcare Corp. Announces Executive Changes	05-07	CI
Definitive Healthcare Corp. (NasdaqGS:DH) announces an Equity Buyback for $20 million worth of its shares.	05-07	CI
Definitive Healthcare Corp. Provides Earnings Guidance for the Second Quarter and Full Year 2024	05-07	CI
Definitive Healthcare Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
Definitive Healthcare Corp. authorizes a Buyback Plan.	05-06	CI
Definitive Healthcare Introduces Carevoyance Sales Enablement Solution for Medtech Industry	04-16	CI
Definitive Healthcare Collaborating With VML Health on Key Opinion Leader Management Tool for Clients	03-22	MT
Definitive Healthcare and VML Health Announce Partnership to Transform Key Opinion Leader Management	03-22	CI
Deutsche Bank Adjusts Definitive Healthcare Price Target to $10 From $9, Maintains Hold Rating	03-01	MT
Barclays Adjusts Price Target on Definitive Healthcare to $11 From $10, Maintains Equalweight Rating	03-01	MT
Definitive Healthcare Seeks Inorganic Growth	02-28	CI
Transcript : Definitive Healthcare Corp., Q4 2023 Earnings Call, Feb 28, 2024	02-28
Earnings Flash (DH) DEFINITIVE HEALTHCARE Reports Q4 EPS $0.07, vs. Street Est of $0.08	02-28	MT
Earnings Flash (DH) DEFINITIVE HEALTHCARE Posts Q4 Revenue $65.9M, vs. Street Est of $66M	02-28	MT

Chart Definitive Healthcare Corp.

Duration

Period

More charts

Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Companyâs solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. All of its business is conducted through AIDH TopCo, LLC (Definitive OpCo).

Sector

Software

Calendar

31/07/2024 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Definitive Healthcare Corp.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

5.15 USD

Average target price

8.45 USD

Spread / Average Target

+64.08%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
DEFINITIVE HEALTHCARE CORP.	-48.19%	632M
SYNOPSYS INC.	+16.55%	91.26B
CADENCE DESIGN SYSTEMS, INC.	+14.38%	84.76B
PALANTIR TECHNOLOGIES INC.	+43.04%	53.8B
DASSAULT SYSTÈMES SE	-20.43%	49.15B
THE TRADE DESK, INC.	+35.81%	46.84B
SEA LIMITED	+83.19%	43.59B
ATLASSIAN CORPORATION	-29.60%	42.88B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-1.19%	27.95B
ROBLOX CORPORATION	-22.51%	22.52B

Other Software